Apeloa Pharmaceutical Co Ltd (000739) — Free Cash Flow Generation Index
Apeloa Pharmaceutical Co Ltd (000739) has a Free Cash Flow Generation Index of 0.63x as of December 2025. Free cash flow of CN¥279.45 Million represents 1% of operating cash flow (CN¥446.18 Million). See Apeloa Pharmaceutical Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Apeloa Pharmaceutical Co Ltd Free Cash Flow Generation Index (1998–2025)
Historical FCF Generation Index trend for Apeloa Pharmaceutical Co Ltd across 26 annual periods. Explore Apeloa Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Apeloa Pharmaceutical Co Ltd (1998–2025)
Year-by-year Free Cash Flow Generation Index for Apeloa Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Apeloa Pharmaceutical Co Ltd market cap and net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.69x | CN¥844.46 Million | CN¥1.23 Billion | CN¥386.21 Million | ▲ +10.9% |
| 2024 | 0.62x | CN¥748.01 Million | CN¥1.21 Billion | CN¥460.75 Million | ▲ +59.2% |
| 2023 | 0.39x | CN¥400.90 Million | CN¥1.03 Billion | CN¥630.47 Million | ▼ -36.9% |
| 2022 | 0.62x | CN¥817.00 Million | CN¥1.33 Billion | CN¥509.11 Million | ▲ +518.0% |
| 2021 | -0.15x | CN¥-90.18 Million | CN¥611.75 Million | CN¥701.92 Million | ▼ -121.0% |
| 2020 | 0.70x | CN¥742.41 Million | CN¥1.06 Billion | CN¥317.12 Million | ▼ -28.2% |
| 2019 | 0.98x | CN¥1.33 Billion | CN¥1.36 Billion | CN¥31.85 Million | ▲ +8.3% |
| 2018 | 0.90x | CN¥751.07 Million | CN¥832.69 Million | CN¥81.62 Million | ▲ +308.0% |
| 2017 | 0.22x | CN¥46.38 Million | CN¥209.80 Million | CN¥163.42 Million | ▲ +126.4% |
| 2016 | -0.84x | CN¥-150.93 Million | CN¥180.42 Million | CN¥331.35 Million | ▼ -3285.0% |
| 2015 | -0.02x | CN¥-10.90 Million | CN¥441.16 Million | CN¥452.06 Million | ▼ -107.9% |
| 2014 | 0.31x | CN¥246.42 Million | CN¥786.64 Million | CN¥540.22 Million | ▲ +119.0% |
| 2013 | -1.65x | CN¥-314.56 Million | CN¥190.45 Million | CN¥505.01 Million | ▼ -14928.1% |
| 2012 | -0.01x | CN¥-3.69 Million | CN¥335.90 Million | CN¥339.59 Million | ▲ +95.9% |
| 2011 | -0.27x | CN¥-107.47 Million | CN¥404.62 Million | CN¥289.21 Million | ▼ -71.4% |
| 2010 | -0.15x | CN¥-18.76 Million | CN¥121.05 Million | CN¥139.81 Million | ▼ -128.2% |
| 2009 | 0.55x | CN¥114.64 Million | CN¥208.30 Million | CN¥93.66 Million | ▲ +120.5% |
| 2008 | -2.69x | CN¥-254.47 Million | CN¥94.57 Million | CN¥349.04 Million | ▼ -901.3% |
| 2007 | 0.34x | CN¥58.50 Million | CN¥174.20 Million | CN¥115.70 Million | ▼ -49.3% |
| 2006 | 0.66x | CN¥105.58 Million | CN¥159.43 Million | CN¥53.84 Million | ▲ +269.0% |
| 2005 | -0.39x | CN¥-34.26 Million | CN¥87.40 Million | CN¥121.65 Million | ▲ +70.7% |
| 2004 | -1.34x | CN¥-63.52 Million | CN¥47.54 Million | CN¥111.07 Million | ▼ -915.2% |
| 2003 | 0.16x | CN¥17.27 Million | CN¥105.36 Million | CN¥88.09 Million | ▲ +101.0% |
| 2002 | -15.78x | CN¥-44.42 Million | CN¥2.81 Million | CN¥47.23 Million | ▼ -2991.4% |
| 2000 | 0.55x | CN¥3.86 Million | CN¥7.08 Million | CN¥3.22 Million | ▲ +20.2% |
| 1998 | 0.45x | CN¥13.66 Million | CN¥30.10 Million | CN¥16.43 Million | — |